These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 9665015)

  • 1. Soluble donor MHC class I antigen inhibits immunologic priming in vitro and in vivo.
    Geissler EK; Scherer MN; Graeb C
    Transpl Int; 1998; 11 Suppl 1():S357-60. PubMed ID: 9665015
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunologic suppression mediated by genetically modified hepatocytes expressing secreted allo-MHC class I molecules.
    Graeb C; Scherer MN; Knechtle SJ; Geissler EK
    Hum Immunol; 1998 Jul; 59(7):415-25. PubMed ID: 9684991
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Secreted donor-MHC class I antigen prolongs liver allograft survival and inhibits recipient anti-donor cytotoxic T lymphocyte responses.
    Geissler EK; Korzun WJ; Graeb C
    Transplantation; 1997 Sep; 64(5):782-6. PubMed ID: 9311723
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Prevention of early rejection by soluble MHC class I antigen after allogenic liver transplantation].
    Geissler EK; Scherer MN; Jauch KW; Graeb C
    Langenbecks Arch Chir Suppl Kongressbd; 1998; 115(Suppl I):641-4. PubMed ID: 14518333
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effective use of donor MHC class I gene therapy in organ transplantation: prevention of antibody-mediated hyperacute heart allograft rejection in highly sensitized rat recipients.
    Geissler EK; Graeb C; Tange S; Guba M; Jauch KW; Scherer MN
    Hum Gene Ther; 2000 Feb; 11(3):459-69. PubMed ID: 10697120
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunologic considerations for therapeutic strategies utilizing allogeneic hepatocytes: hepatocyte-expressed membrane-bound major histocompatibility complex class I antigen sensitizes while soluble antigen suppresses the immune response in rats.
    Scherer MN; Graeb C; Tange S; Dyson C; Jauch KW; Geissler EK
    Hepatology; 2000 Nov; 32(5):999-1007. PubMed ID: 11050050
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hepatocyte expression of soluble donor MHC class I antigen via gene transfer inhibits multiple aspects of the antidonor immune response in fully sensitized rat transplant recipients.
    Graeb C; Scherer MN; Kroemer A; Jauch KW; Geissler EK
    Hum Immunol; 2002 Oct; 63(10):948-54. PubMed ID: 12368047
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Induction of specific allograft immunity by soluble class I MHC heavy chain protein produced in a baculovirus expression system.
    Wang M; Stepkowski SM; Wang ME; Tian L; Qu X; Tu Y; He G; Kahan BD
    Transplantation; 1996 Feb; 61(3):448-57. PubMed ID: 8610360
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparative studies of specific acquired systemic tolerance induced by intrathymic inoculation of a single synthetic Wistar-Furth (RT1U) allo-MHC class I (RT1.AU) peptide or WAG (RT1U)-derived class I peptide.
    Chowdhury NC; Saborio DV; Garrovillo M; Chandraker A; Magee CC; Waaga AM; Sayegh MH; Jin MX; Oluwole SF
    Transplantation; 1998 Oct; 66(8):1059-66. PubMed ID: 9808492
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Soluble donor MHC class I gene transfer to thymus promotes allograft survival in a high-responder heart transplant model.
    Geissler EK; Scherer MN; Graeb C
    Transpl Int; 2000; 13 Suppl 1():S452-5. PubMed ID: 11112052
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MHC class II presenting cells are necessary for the induction of intrathymic tolerance.
    Goss JA; Nakafusa Y; Flye MW
    Ann Surg; 1993 May; 217(5):492-9; discussion 499-501. PubMed ID: 8489312
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunity to MHC class I antigen after direct DNA transfer into skeletal muscle.
    Geissler EK; Wang J; Fechner JH; Burlingham WJ; Knechtle SJ
    J Immunol; 1994 Jan; 152(2):413-21. PubMed ID: 8283029
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Donor MHC class I peptides in conjunction with self-epitopes induce donor-specific tolerance in a dose-dependent manner but unable to abrogate chronic rejection.
    Semiletova NV; Shen XD; Feldman DM; Busuttil RW; Kupiec-Weglinski JW; Ghobrial RM
    Transplant Proc; 2005 May; 37(4):1937-9. PubMed ID: 15919510
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A detailed analysis of the potential of water-soluble classical class I MHC molecules for the suppression of kidney allograft rejection and in vitro cytotoxic T cell responses.
    Priestley CA; Dalchau R; Sawyer GJ; Fabre JW
    Transplantation; 1989 Dec; 48(6):1031-8. PubMed ID: 2595764
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Direct MHC class I complementary DNA transfer to thymus induces donor-specific unresponsiveness, which involves multiple immunologic mechanisms.
    Knechtle SJ; Wang J; Graeb C; Zhai Y; Hong X; Fechner JH; Geissler EK
    J Immunol; 1997 Jul; 159(1):152-8. PubMed ID: 9200450
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Donor-derived soluble MHC antigens plus low-dose cyclosporine induce transplantation unresponsiveness independent of the thymus by down-regulating T cell-mediated alloresponses in a rat transplantation model.
    Behrens D; Lange K; Fried A; Yoo-Ott KA; Richter K; Fändrich F; Krönke M; Zavazava N
    Transplantation; 2001 Dec; 72(12):1974-82. PubMed ID: 11773898
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Portal vein administration of donor cells promotes peripheral allospecific hyporesponsiveness and graft tolerance.
    Yu S; Nakafusa Y; Flye MW
    Surgery; 1994 Aug; 116(2):229-34; discussion 234-5. PubMed ID: 8047989
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Epitope mapping of the indirect T cell response to allogeneic class I MHC: sequences shared by donor and recipient MHC may prime T cells that provide help for alloantibody production.
    Lovegrove E; Pettigrew GJ; Bolton EM; Bradley JA
    J Immunol; 2001 Oct; 167(8):4338-44. PubMed ID: 11591757
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Induction of transplantation tolerance by chimeric donor/recipient class I RT1.Aa molecules.
    Ghobrial RR; Hamashima T; Wang ME; Wang M; Stepkowski SM; Kahan BD
    Transplantation; 1996 Oct; 62(7):1002-10. PubMed ID: 8878396
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mechanisms of indirect allorecognition in graft rejection: class II MHC allopeptide-specific T cell clones transfer delayed-type hypersensitivity responses in vivo.
    Chen W; Murphy B; Waaga AM; Willett TA; Russell ME; Khoury SJ; Sayegh MH
    Transplantation; 1996 Sep; 62(6):705-10. PubMed ID: 8824464
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.